PRACS | The industry’s leading early phase CRO

Small to Mid-Size Biopharmaceuticals

Why PRACS is the Choice for Small to Mid-Size Biopharmaceutical Companies

We’ll speed you to the next milestone while avoiding the bumps in the road. Because the faster you reach each milestone...
Large Pharmaceuticals

Why PRACS is the Choice for Large Pharmaceutical Companies

We help you make the best decisions about which new compounds have the most potential to become significant additions to your portfolio.
Generic Pharmaceuticals

Why PRACS is the Choice for Generic Companies

We’ll take you beyond bioequivalence and right through your regulatory submission. At PRACS, we specialize in early phase, and that means…

PRACS – Innovative, Flexible, Dedicated Industry Leaders

At PRACS we know our business—and are committed to forward-thinking service. This is how we earned our reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services.

Knowledge and understanding come from experience. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services designed for Phase I/IIa.